FREQ Frequency Therapeutics Inc

0.0266 (7.17%)
Last Updated: 12:39:49
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 40,503
Bid Price 0.3901
Ask Price 0.3975
News -
Day High 0.41


52 Week Range


Day Low 0.375
Company Name Stock Ticker Symbol Market Type
Frequency Therapeutics Inc FREQ NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0266 7.17% 0.3975 12:39:49
Open Price Low Price High Price Close Price Prev Close
0.39 0.375 0.41 0.3709
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
153 40,503 $ 0.3886829 $ 15,743 - 0.3258 - 5.59
Last Trade Time Type Quantity Stock Price Currency
12:39:37 14 $ 0.3901 USD

Frequency Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
14.52M 36.52M - 0 -81.58M -2.23 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Frequency Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No FREQ Message Board. Create One! See More Posts on FREQ Message Board See More Message Board Posts

Historical FREQ Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.38110.42990.350.376230361,0820.01644.3%
1 Month0.490.490.350.420269392,271-0.0925-18.88%
3 Months0.370.81010.340.6813491,845,7300.02757.43%
6 Months0.45140.81010.32580.6542323950,765-0.0539-11.94%
1 Year1.865.590.32580.9611359713,227-1.46-78.63%
3 Years19.8658.370.32586.24565,989-19.46-98.0%
5 Years11.2058.370.32587.47466,293-10.80-96.45%

Frequency Therapeutics Description

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.
Your Recent History
Frequency ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now